{"id":2916771,"date":"2023-10-03T08:29:44","date_gmt":"2023-10-03T12:29:44","guid":{"rendered":"https:\/\/wordpress-1016567-4521551.cloudwaysapps.com\/plato-data\/five-cannabis-stories-you-might-have-missed\/"},"modified":"2023-10-03T08:29:44","modified_gmt":"2023-10-03T12:29:44","slug":"five-cannabis-stories-you-might-have-missed","status":"publish","type":"station","link":"https:\/\/platodata.io\/plato-data\/five-cannabis-stories-you-might-have-missed\/","title":{"rendered":"Five Cannabis Stories You Might Have Missed"},"content":{"rendered":"

What are the five cannabis<\/a> stories you might have missed? Nowadays, it\u2019s impossible to keep up with cannabis news stories across the world. Whether it\u2019s banking reform and rescheduling in the United States, legalization<\/a> in Europe or Thailand, or Canada\u2019s experiment with corporate legalization.<\/p>\n

Here are five cannabis stories you might have missed.<\/h2>\n

Suing Over Cannabis Rescheduling<\/h3>\n
\n
\"Suing<\/a><\/figure>\n<\/div>\n

U.S. Attorney Matthew Zorn is suing<\/a> the Biden Administration over cannabis rescheduling, particularly over the secrecy of it all. If you missed this cannabis story, here are the details.<\/p>\n

Last month, the U.S. Health and Human Services Department (HHS) sent a letter to the Drug Enforcement Administration (DEA<\/a>) suggesting they reschedule cannabis.<\/p>\n

Currently, the U.S. government lists cannabis as a Schedule 1 drug, in the same category as heroin. The HHS letter suggests it should be a Schedule 3. Cannabis would still be a controlled substance but with fewer restrictions.<\/p>\n

U.S. Attorney Matthew Zorn has filed an official complaint in the U.S. District Court. He says the letter \u201chas become an item of public interest.\u201d He has asked the court to force the Biden Administration to release \u201cimproperly held agency records.\u201d<\/p>\n

Zorn tried a Freedom of Information Act request but to no avail. HHS \u201chas not produced the requested record\u201d and \u201cdid not make a timely determination within 20 days,\u201d the complaint alleges.<\/p>\n

60% Higher Risk of Cardiovascular Problems Linked to \u201cCannabis Use Disorder\u201d<\/h3>\n

Another day, another study finding an \u201cassociation\u201d between cannabis and something terrible. This time, it\u2019s cardiovascular problems.<\/a> You haven\u2019t missed much if you missed this cannabis news story.<\/p>\n

Here are some problems with the study:<\/p>\n

Correlation is not Causation. <\/strong>Like most of these \u201ccannabis is bad for you\u201d studies, the researchers have merely made an association. Fortunately, this study explicitly states there is no causation. They simply found an association after controlling for variables. <\/p>\n

Confounding Variables. <\/strong>While the study adjusts for some variables, it says it cannot account for tobacco<\/a> smoking<\/a> due to data limitations. This is obviously a significant limitation.<\/p>\n

Smoking<\/a> cigarettes is a far more significant risk factor for cardiovascular diseases than smoking cannabis.<\/p>\n

Not being able to parse out this variable makes the study beyond useless. It\u2019s literally disinformation. If you missed this cannabis news story, then you\u2019re better off for it. <\/p>\n

Sampling Cannabis in British Columbia \u2013 A Cannabis Story You Might Have Missed<\/h3>\n
\n
\"Sampling<\/a><\/figure>\n<\/div>\n

You might have missed this cannabis story out of British Columbia<\/a>, Canada.<\/p>\n

After years of stigma and drug war propaganda, the British Columbia government is finally starting to loosen their<\/a> cannabis rules and regulations.<\/p>\n

Licensed producers<\/a> can now provide samples for retailers. The Grow Up Conference and Expo was the first cannabis industry<\/a> event to take advantage of the new rules.<\/p>\n

Advocates say the new regulations will benefit the industry in several ways. Retailers will now be able to see the product they\u2019re buying and sample it for their customers.<\/p>\n

Unfortunately, retailers cannot provide samples to customers yet. But the industry is hopeful that it\u2019s in the works. That\u2019s undoubtedly a cannabis new story we wouldn\u2019t want to miss.<\/p>\n

Thailand To Reconsider Cannabis Decriminalization<\/h3>\n

You might have missed this vital cannabis news story: Thailand may re-criminalize cannabis.<\/a><\/p>\n

Two years ago, Thailand became the first Asian country to decriminalize cannabis. But its government, led by Prime Minister Srettha Thavisin, has vowed to roll back cannabis legalization.<\/p>\n

In an interview with Bloomberg Television in New York while attending the UN General Assembly, Srettah made clear that residents of the country will only be able to use cannabis for medical reasons.<\/p>\n

\u201cIt\u2019s just for medical reasons. We need to rewrite the law,\u201d he said.<\/p>\n

Current legislation has cannabis removed from a list of narcotics. Individuals are supposed to notify their local government if they want to cultivate plants at home. But so far, the government has not created any regulations regarding cultivation and sales. <\/p>\n

This regulatory vacuum has created a \u201cfree-for-all\u201d industry much like the \u201cwild-west\u201d of British Columbia before Justin Trudeau\u2019s corporate cannabis takeover.<\/p>\n

While some estimated Thailand\u2019s cannabis market<\/a> may be worth nearly $2 billion, the new government ensures that money will remain in the black market<\/a>.<\/p>\n

SAFER Banking Almost a Reality \u2013 The Fifth Cannabis Story Might Gone Unnoticed<\/h3>\n
\n
\"SAFER<\/a><\/figure>\n<\/div>\n

We covered this one,<\/a> but you might have missed this important cannabis news story.<\/p>\n

Less than a week after being re-introduced, the SAFER Banking Act found approval by the Senate Banking Committee on September 27. The committee voted 14-9 to advance the legislation to the Senate floor.<\/p>\n

The text of the new amendment is not yet available publicly. But give it enough time, and U.S. Attorney Matthew Zorn may sue to get the details released. <\/p>\n

But overall, thanks to this committee, the movement toward cannabis reform in the United States just got a shot in the arm.<\/p>\n